Jianing Ying
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jianing Ying has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Quanyong Yi
Wenzhou Medical University
3 shared publications Yanyan Zhang
Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital Wenzhou Medical University Ningbo China
2 shared publicationsYue Du
Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital Wenzhou Medical University Ningbo China
2 shared publications- Baihua Li
Department of Computer Science, Loughborough University, Loughborough, UK
1 shared publication - Da Chen
Shandong Artificial Intelligence Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
1 shared publication - Dan Zhang
School of Cyber Science and Engineering, Ningbo University of Technology, Ningbo, China
1 shared publication
Latest Publications
- Open Access
- 4 September 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (9) , e71112
Fatty Acid‐Binding Protein 5 Potentially Regulates the Proliferation and Metastasis of Uveal Melanoma Cells Through the PI3K / AKT / mTOR Signaling Pathway
Background: Uveal melanoma (UVM) is an aggressive intraocular tumor with limited effective treatments for metastatic disease. This study explored the pathways through which fatty acid‐binding protein 5 ( FABP5 ) promoted UVM progression. Methods: Single‐cell RNA sequencing datasets were preprocessed by the Seurat package, and prognostic genes were screened using the survival package. A prognostic model was constructed via LASSO Cox regression, followed by Kaplan–Meier (KM) survival analysis. To characterize the tumor immune microenvironment, we evaluated immune cell infiltration using ssGSEA, ESTIMATE, and CIBERSORT algorithms, while GSEA was applied to identify enriched pathways. Additionally, immunotherapy response was predicted by TIDE, and tumor mutation burden (TMB) was calculated using Maftools. For in vivo validation, a nude mouse xenograft model was established, and Western blotting was performed on tumor tissues harvested from the xenograft assay. Results: SPON2 , MATK , and FABP5 were identified as hub genes in UVM and used to construct a prognostic model with a high AUC. Immune infiltration analysis revealed that high‐risk patients exhibited features of immune evasion. Enrichment analysis further revealed that cytotoxic T‐cell‐related genes ( MATK and FABP5 ) were enriched in the PI3K/AKT/mTOR pathway. FABP5 was overexpressed in UVM cells, whereas FABP5 silencing suppressed cell viability, proliferation, migration, and invasion, reduced MMP2 and MMP9 levels, promoted apoptosis, downregulated PI3K/AKT/mTOR pathway‐related molecules, and upregulated apoptosis‐related proteins. Notably, these effects could be reversed by the PI3K agonist 740Y‐P. Conclusion: FABP5 promoted UVM cell proliferation and migration through the PI3K/AKT/mTOR pathway. Though the immune‐infiltration analysis was hypothesis‐generating, it may help identify patients likely to benefit from immunotherapy.
- 4 September 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (9) , e71112
Open AccessFatty Acid‐Binding Protein 5 Potentially Regulates the Proliferation and Metastasis of Uveal Melanoma Cells Through the PI3K / AKT / mTOR Signaling Pathway
Background: Uveal melanoma (UVM) is an aggressive intraocular tumor with limited effective treatments for metastatic disease. This study explored the pathways through which fatty acid‐binding protein 5 ( FABP5 ) promoted UVM progression. Methods: Single‐cell RNA sequencing datasets were preprocessed by the Seurat package, and prognostic genes were screened using the survival package. A prognostic model was constructed via LASSO Cox regression, followed by Kaplan–Meier (KM) survival analysis. To characterize the tumor immune microenvironment, we evaluated immune cell infiltration using ssGSEA, ESTIMATE, and CIBERSORT algorithms, while GSEA was applied to identify enriched pathways. Additionally, immunotherapy response was predicted by TIDE, and tumor mutation burden (TMB) was calculated using Maftools. For in vivo validation, a nude mouse xenograft model was established, and Western blotting was performed on tumor tissues harvested from the xenograft assay. Results: SPON2 , MATK , and FABP5 were identified as hub genes in UVM and used to construct a prognostic model with a high AUC. Immune infiltration analysis revealed that high‐risk patients exhibited features of immune evasion. Enrichment analysis further revealed that cytotoxic T‐cell‐related genes ( MATK and FABP5 ) were enriched in the PI3K/AKT/mTOR pathway. FABP5 was overexpressed in UVM cells, whereas FABP5 silencing suppressed cell viability, proliferation, migration, and invasion, reduced MMP2 and MMP9 levels, promoted apoptosis, downregulated PI3K/AKT/mTOR pathway‐related molecules, and upregulated apoptosis‐related proteins. Notably, these effects could be reversed by the PI3K agonist 740Y‐P. Conclusion: FABP5 promoted UVM cell proliferation and migration through the PI3K/AKT/mTOR pathway. Though the immune‐infiltration analysis was hypothesis‐generating, it may help identify patients likely to benefit from immunotherapy.
- 20 November 2025
- Published by Elsevier in Pattern Recognition
- Vol. 172
MTD-Net: A robust multi-task discriminative network for choroidal neovascularization segmentation
- 20 November 2025
- Published by Elsevier in Pattern Recognition
- Vol. 172
MTD-Net: A robust multi-task discriminative network for choroidal neovascularization segmentation
- Open Access
- 17 July 2025
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 55, 104728
Deep learning-based quantitative assessment inflammatory response of hyperreflective foci in diabetic macular edema
- 17 July 2025
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 55, 104728
Open AccessDeep learning-based quantitative assessment inflammatory response of hyperreflective foci in diabetic macular edema